arrow
Y

Yevgeniy R. Semenov

Harvard Medical School
H指数:36
被引数:3,724

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acral melanoma: a unique subtype requiring unique solutions

肢端黑色素瘤:一种需要独特解决方案的独特亚型

2026-11-030
PRE
Risk and protective factors for uveal melanoma: Evidence for a protective role of autoimmune and immune-mediated conditions

脉络膜黑色素瘤的风险和保护因素:自身免疫和免疫介导条件具有保护作用的证据

2026-07-010
PRE
Incubating Artificial Intelligence (AI) Initiatives and Careers in Dermatology

孵化人工智能(AI)在皮肤病学领域的倡议与职业发展

2026-04-010
PRE
Type 2 Immunity Links Eczematous and Lichenoid Eruptions Caused by Immune Checkpoint Inhibitors

2型免疫将免疫检查点抑制剂引起的湿疹样和苔藓样皮疹联系起来

2025-08-080
PRE
Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens

黄,M.; 王,D.; 黄,J.; Bae, A.N.; 夏,Y.; 赵,X.; Mortaja, M.; Azin, M.; Collier, M.R.; Semenov, Y.R.; 等. 乙型肝炎病毒通过调节对环境致癌物的免疫反应促进肝癌。Nat. Commun. 2025, 16, 5360. [Google Scholar] [CrossRef] [PubMed]

2025-06-270
OAAI
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events

接受度普利尤单抗治疗皮肤免疫相关不良事件的患者长期死亡率结局

2025-05-120
OA
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center

具有临床影响的欧洲癌症登月计划隆德中心综合生物样本库策略

2025-05-010
OAAI
Precision phenotyping for curating research cohorts of patients with unexplained post-acute sequelae of COVID-19

针对不明原因的COVID-19急性期后后遗症患者的精准表型分析,以整理研究队列

MED
IF11.8
2024-11-012
OAAI